Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis

SAN DIEGO, Feb. 5, 2013 -- (Healthcare Sales & Marketing Network) -- Somaxon Pharmaceuticals, Inc. (SOMX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Elizabeth LLC and Actavis Inc. to re... Biopharmaceuticals, Generics, LitigationSomaxon Pharmaceuticals, Actavis Elizabeth, Silenor, doxepin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news